Correlation Between Sprint Bioscience and Generic Sweden

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sprint Bioscience and Generic Sweden at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprint Bioscience and Generic Sweden into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sprint Bioscience AB and Generic Sweden publ, you can compare the effects of market volatilities on Sprint Bioscience and Generic Sweden and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprint Bioscience with a short position of Generic Sweden. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprint Bioscience and Generic Sweden.

Diversification Opportunities for Sprint Bioscience and Generic Sweden

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Sprint and Generic is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Sprint Bioscience AB and Generic Sweden publ in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Generic Sweden publ and Sprint Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprint Bioscience AB are associated (or correlated) with Generic Sweden. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Generic Sweden publ has no effect on the direction of Sprint Bioscience i.e., Sprint Bioscience and Generic Sweden go up and down completely randomly.

Pair Corralation between Sprint Bioscience and Generic Sweden

Assuming the 90 days trading horizon Sprint Bioscience AB is expected to under-perform the Generic Sweden. In addition to that, Sprint Bioscience is 2.65 times more volatile than Generic Sweden publ. It trades about -0.11 of its total potential returns per unit of risk. Generic Sweden publ is currently generating about 0.26 per unit of volatility. If you would invest  4,640  in Generic Sweden publ on September 15, 2024 and sell it today you would earn a total of  440.00  from holding Generic Sweden publ or generate 9.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sprint Bioscience AB  vs.  Generic Sweden publ

 Performance 
       Timeline  
Sprint Bioscience 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sprint Bioscience AB are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Sprint Bioscience sustained solid returns over the last few months and may actually be approaching a breakup point.
Generic Sweden publ 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Generic Sweden publ are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Generic Sweden unveiled solid returns over the last few months and may actually be approaching a breakup point.

Sprint Bioscience and Generic Sweden Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sprint Bioscience and Generic Sweden

The main advantage of trading using opposite Sprint Bioscience and Generic Sweden positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprint Bioscience position performs unexpectedly, Generic Sweden can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generic Sweden will offset losses from the drop in Generic Sweden's long position.
The idea behind Sprint Bioscience AB and Generic Sweden publ pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world